Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LRE1 is a specific and allosteric soluble adenylyl cyclase inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 189.00 | |
50 mg | In stock | $ 355.00 | |
100 mg | In stock | $ 529.00 | |
500 mg | In stock | $ 1,180.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | LRE1 is a specific and allosteric soluble adenylyl cyclase inhibitor. |
In vitro | LRE1 prevents sAC-dependent processes in cellular and physiological systems and facilitates exploration of the therapeutic potential of sAC inhibition. LRE1 binds to the bicarbonate activator binding site and suppresses soluble adenylyl cyclase (sAC) via a unique allosteric mechanism[1]. |
Molecular Weight | 280.78 |
Formula | C12H13ClN4S |
CAS No. | 1252362-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 112.5 mg/mL (400.7 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LRE1 1252362-53-0 Neuroscience Adenylyl cyclase LRE-1 LRE 1 inhibitor inhibit